nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—CYP1A1—hypertension	0.277	1	CbGaD
Dicyclomine—CHRM3—Nicardipine—hypertension	0.0484	0.134	CbGbCtD
Dicyclomine—CYP1A1—Prazosin—hypertension	0.0446	0.123	CbGbCtD
Dicyclomine—CHRM1—Nicardipine—hypertension	0.0421	0.116	CbGbCtD
Dicyclomine—CYP1A1—Amlodipine—hypertension	0.0419	0.116	CbGbCtD
Dicyclomine—CYP1A1—Nifedipine—hypertension	0.0391	0.108	CbGbCtD
Dicyclomine—CHRM2—Nicardipine—hypertension	0.0388	0.107	CbGbCtD
Dicyclomine—CYP1A1—Carvedilol—hypertension	0.0385	0.106	CbGbCtD
Dicyclomine—CYP1A1—Propranolol—hypertension	0.0354	0.0976	CbGbCtD
Dicyclomine—CYP1A1—Clonidine—hypertension	0.0338	0.0932	CbGbCtD
Dicyclomine—Confusional state—Ramipril—hypertension	5.13e-05	0.000213	CcSEcCtD
Dicyclomine—Discomfort—Timolol—hypertension	5.12e-05	0.000213	CcSEcCtD
Dicyclomine—Rash—Doxazosin—hypertension	5.12e-05	0.000212	CcSEcCtD
Dicyclomine—Fatigue—Losartan—hypertension	5.11e-05	0.000212	CcSEcCtD
Dicyclomine—Dermatitis—Doxazosin—hypertension	5.11e-05	0.000212	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Hydrochlorothiazide—hypertension	5.11e-05	0.000212	CcSEcCtD
Dicyclomine—Vomiting—Fosinopril—hypertension	5.1e-05	0.000211	CcSEcCtD
Dicyclomine—Malaise—Lisinopril—hypertension	5.1e-05	0.000211	CcSEcCtD
Dicyclomine—Nausea—Propranolol—hypertension	5.09e-05	0.000211	CcSEcCtD
Dicyclomine—Anaphylactic shock—Ramipril—hypertension	5.08e-05	0.000211	CcSEcCtD
Dicyclomine—Oedema—Ramipril—hypertension	5.08e-05	0.000211	CcSEcCtD
Dicyclomine—Headache—Doxazosin—hypertension	5.08e-05	0.000211	CcSEcCtD
Dicyclomine—Dry mouth—Timolol—hypertension	5.07e-05	0.00021	CcSEcCtD
Dicyclomine—Pain—Losartan—hypertension	5.07e-05	0.00021	CcSEcCtD
Dicyclomine—Constipation—Losartan—hypertension	5.07e-05	0.00021	CcSEcCtD
Dicyclomine—Syncope—Lisinopril—hypertension	5.07e-05	0.00021	CcSEcCtD
Dicyclomine—Vomiting—Eplerenone—hypertension	5.07e-05	0.00021	CcSEcCtD
Dicyclomine—Feeling abnormal—Furosemide—hypertension	5.06e-05	0.00021	CcSEcCtD
Dicyclomine—Rash—Fosinopril—hypertension	5.05e-05	0.00021	CcSEcCtD
Dicyclomine—Dermatitis—Fosinopril—hypertension	5.05e-05	0.000209	CcSEcCtD
Dicyclomine—Vomiting—Nifedipine—hypertension	5.03e-05	0.000209	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Furosemide—hypertension	5.03e-05	0.000208	CcSEcCtD
Dicyclomine—Rash—Eplerenone—hypertension	5.02e-05	0.000208	CcSEcCtD
Dicyclomine—Urticaria—Perindopril—hypertension	5.02e-05	0.000208	CcSEcCtD
Dicyclomine—Headache—Fosinopril—hypertension	5.02e-05	0.000208	CcSEcCtD
Dicyclomine—Hypersensitivity—Trandolapril—hypertension	5.02e-05	0.000208	CcSEcCtD
Dicyclomine—Dermatitis—Eplerenone—hypertension	5.02e-05	0.000208	CcSEcCtD
Dicyclomine—Asthenia—Clonidine—hypertension	5.01e-05	0.000208	CcSEcCtD
Dicyclomine—Feeling abnormal—Betaxolol—hypertension	5.01e-05	0.000208	CcSEcCtD
Dicyclomine—Confusional state—Timolol—hypertension	5.01e-05	0.000208	CcSEcCtD
Dicyclomine—Vomiting—Verapamil—hypertension	5.01e-05	0.000208	CcSEcCtD
Dicyclomine—Urticaria—Irbesartan—hypertension	5.01e-05	0.000208	CcSEcCtD
Dicyclomine—Shock—Ramipril—hypertension	5e-05	0.000208	CcSEcCtD
Dicyclomine—Hypersensitivity—Enalapril—hypertension	5e-05	0.000208	CcSEcCtD
Dicyclomine—Abdominal pain—Perindopril—hypertension	5e-05	0.000207	CcSEcCtD
Dicyclomine—Palpitations—Lisinopril—hypertension	4.99e-05	0.000207	CcSEcCtD
Dicyclomine—Headache—Eplerenone—hypertension	4.99e-05	0.000207	CcSEcCtD
Dicyclomine—Rash—Nifedipine—hypertension	4.99e-05	0.000207	CcSEcCtD
Dicyclomine—Nervous system disorder—Ramipril—hypertension	4.99e-05	0.000207	CcSEcCtD
Dicyclomine—Dermatitis—Nifedipine—hypertension	4.98e-05	0.000207	CcSEcCtD
Dicyclomine—Abdominal pain—Irbesartan—hypertension	4.98e-05	0.000207	CcSEcCtD
Dicyclomine—Anaphylactic shock—Timolol—hypertension	4.97e-05	0.000206	CcSEcCtD
Dicyclomine—Oedema—Timolol—hypertension	4.97e-05	0.000206	CcSEcCtD
Dicyclomine—Loss of consciousness—Lisinopril—hypertension	4.97e-05	0.000206	CcSEcCtD
Dicyclomine—Rash—Verapamil—hypertension	4.97e-05	0.000206	CcSEcCtD
Dicyclomine—Urticaria—Hydrochlorothiazide—hypertension	4.96e-05	0.000206	CcSEcCtD
Dicyclomine—Tachycardia—Ramipril—hypertension	4.96e-05	0.000206	CcSEcCtD
Dicyclomine—Dermatitis—Verapamil—hypertension	4.96e-05	0.000206	CcSEcCtD
Dicyclomine—Headache—Nifedipine—hypertension	4.96e-05	0.000206	CcSEcCtD
Dicyclomine—Pruritus—Clonidine—hypertension	4.94e-05	0.000205	CcSEcCtD
Dicyclomine—Abdominal pain—Hydrochlorothiazide—hypertension	4.94e-05	0.000205	CcSEcCtD
Dicyclomine—Headache—Verapamil—hypertension	4.93e-05	0.000205	CcSEcCtD
Dicyclomine—Hypersensitivity—Telmisartan—hypertension	4.93e-05	0.000205	CcSEcCtD
Dicyclomine—Nausea—Indapamide—hypertension	4.92e-05	0.000204	CcSEcCtD
Dicyclomine—Nausea—Diltiazem—hypertension	4.92e-05	0.000204	CcSEcCtD
Dicyclomine—Asthenia—Trandolapril—hypertension	4.89e-05	0.000203	CcSEcCtD
Dicyclomine—Shock—Timolol—hypertension	4.89e-05	0.000203	CcSEcCtD
Dicyclomine—Feeling abnormal—Losartan—hypertension	4.89e-05	0.000203	CcSEcCtD
Dicyclomine—Urticaria—Furosemide—hypertension	4.88e-05	0.000203	CcSEcCtD
Dicyclomine—Nervous system disorder—Timolol—hypertension	4.87e-05	0.000202	CcSEcCtD
Dicyclomine—Nausea—Carvedilol—hypertension	4.87e-05	0.000202	CcSEcCtD
Dicyclomine—Asthenia—Enalapril—hypertension	4.87e-05	0.000202	CcSEcCtD
Dicyclomine—Abdominal pain—Furosemide—hypertension	4.86e-05	0.000202	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Losartan—hypertension	4.85e-05	0.000201	CcSEcCtD
Dicyclomine—Dizziness—Valsartan—hypertension	4.85e-05	0.000201	CcSEcCtD
Dicyclomine—Anorexia—Ramipril—hypertension	4.85e-05	0.000201	CcSEcCtD
Dicyclomine—Urticaria—Betaxolol—hypertension	4.83e-05	0.000201	CcSEcCtD
Dicyclomine—Dizziness—Olmesartan—hypertension	4.83e-05	0.0002	CcSEcCtD
Dicyclomine—Pruritus—Trandolapril—hypertension	4.82e-05	0.0002	CcSEcCtD
Dicyclomine—Nausea—Doxazosin—hypertension	4.82e-05	0.0002	CcSEcCtD
Dicyclomine—Asthenia—Telmisartan—hypertension	4.8e-05	0.000199	CcSEcCtD
Dicyclomine—Pruritus—Enalapril—hypertension	4.8e-05	0.000199	CcSEcCtD
Dicyclomine—Nausea—Fosinopril—hypertension	4.76e-05	0.000198	CcSEcCtD
Dicyclomine—Discomfort—Lisinopril—hypertension	4.75e-05	0.000197	CcSEcCtD
Dicyclomine—Anorexia—Timolol—hypertension	4.74e-05	0.000197	CcSEcCtD
Dicyclomine—Pruritus—Telmisartan—hypertension	4.74e-05	0.000197	CcSEcCtD
Dicyclomine—Nausea—Eplerenone—hypertension	4.73e-05	0.000196	CcSEcCtD
Dicyclomine—Urticaria—Losartan—hypertension	4.71e-05	0.000195	CcSEcCtD
Dicyclomine—Dry mouth—Lisinopril—hypertension	4.7e-05	0.000195	CcSEcCtD
Dicyclomine—Nausea—Nifedipine—hypertension	4.7e-05	0.000195	CcSEcCtD
Dicyclomine—Abdominal pain—Losartan—hypertension	4.69e-05	0.000194	CcSEcCtD
Dicyclomine—Nausea—Verapamil—hypertension	4.68e-05	0.000194	CcSEcCtD
Dicyclomine—Asthenia—Captopril—hypertension	4.67e-05	0.000194	CcSEcCtD
Dicyclomine—Vomiting—Valsartan—hypertension	4.66e-05	0.000193	CcSEcCtD
Dicyclomine—Confusional state—Lisinopril—hypertension	4.65e-05	0.000193	CcSEcCtD
Dicyclomine—Hypersensitivity—Irbesartan—hypertension	4.64e-05	0.000193	CcSEcCtD
Dicyclomine—Vomiting—Olmesartan—hypertension	4.64e-05	0.000192	CcSEcCtD
Dicyclomine—Rash—Valsartan—hypertension	4.62e-05	0.000192	CcSEcCtD
Dicyclomine—Dizziness—Clonidine—hypertension	4.62e-05	0.000192	CcSEcCtD
Dicyclomine—Dermatitis—Valsartan—hypertension	4.62e-05	0.000192	CcSEcCtD
Dicyclomine—Anaphylactic shock—Lisinopril—hypertension	4.61e-05	0.000191	CcSEcCtD
Dicyclomine—Oedema—Lisinopril—hypertension	4.61e-05	0.000191	CcSEcCtD
Dicyclomine—Pruritus—Captopril—hypertension	4.61e-05	0.000191	CcSEcCtD
Dicyclomine—Hypersensitivity—Hydrochlorothiazide—hypertension	4.6e-05	0.000191	CcSEcCtD
Dicyclomine—Rash—Olmesartan—hypertension	4.6e-05	0.000191	CcSEcCtD
Dicyclomine—Insomnia—Ramipril—hypertension	4.6e-05	0.000191	CcSEcCtD
Dicyclomine—Dermatitis—Olmesartan—hypertension	4.6e-05	0.000191	CcSEcCtD
Dicyclomine—Headache—Valsartan—hypertension	4.59e-05	0.000191	CcSEcCtD
Dicyclomine—Headache—Olmesartan—hypertension	4.57e-05	0.00019	CcSEcCtD
Dicyclomine—Paraesthesia—Ramipril—hypertension	4.57e-05	0.000189	CcSEcCtD
Dicyclomine—Shock—Lisinopril—hypertension	4.54e-05	0.000188	CcSEcCtD
Dicyclomine—Asthenia—Perindopril—hypertension	4.54e-05	0.000188	CcSEcCtD
Dicyclomine—Dyspnoea—Ramipril—hypertension	4.53e-05	0.000188	CcSEcCtD
Dicyclomine—Hypersensitivity—Furosemide—hypertension	4.53e-05	0.000188	CcSEcCtD
Dicyclomine—Asthenia—Irbesartan—hypertension	4.52e-05	0.000188	CcSEcCtD
Dicyclomine—Somnolence—Ramipril—hypertension	4.52e-05	0.000188	CcSEcCtD
Dicyclomine—Dizziness—Trandolapril—hypertension	4.51e-05	0.000187	CcSEcCtD
Dicyclomine—Tachycardia—Lisinopril—hypertension	4.5e-05	0.000187	CcSEcCtD
Dicyclomine—Insomnia—Timolol—hypertension	4.5e-05	0.000187	CcSEcCtD
Dicyclomine—Dizziness—Enalapril—hypertension	4.49e-05	0.000186	CcSEcCtD
Dicyclomine—Asthenia—Hydrochlorothiazide—hypertension	4.48e-05	0.000186	CcSEcCtD
Dicyclomine—Hypersensitivity—Betaxolol—hypertension	4.48e-05	0.000186	CcSEcCtD
Dicyclomine—Dyspepsia—Ramipril—hypertension	4.48e-05	0.000186	CcSEcCtD
Dicyclomine—Pruritus—Perindopril—hypertension	4.47e-05	0.000186	CcSEcCtD
Dicyclomine—Paraesthesia—Timolol—hypertension	4.46e-05	0.000185	CcSEcCtD
Dicyclomine—Pruritus—Irbesartan—hypertension	4.46e-05	0.000185	CcSEcCtD
Dicyclomine—Vomiting—Clonidine—hypertension	4.44e-05	0.000184	CcSEcCtD
Dicyclomine—Dyspnoea—Timolol—hypertension	4.43e-05	0.000184	CcSEcCtD
Dicyclomine—Dizziness—Telmisartan—hypertension	4.43e-05	0.000184	CcSEcCtD
Dicyclomine—Pruritus—Hydrochlorothiazide—hypertension	4.42e-05	0.000183	CcSEcCtD
Dicyclomine—Decreased appetite—Ramipril—hypertension	4.42e-05	0.000183	CcSEcCtD
Dicyclomine—Somnolence—Timolol—hypertension	4.42e-05	0.000183	CcSEcCtD
Dicyclomine—Asthenia—Furosemide—hypertension	4.41e-05	0.000183	CcSEcCtD
Dicyclomine—Rash—Clonidine—hypertension	4.41e-05	0.000183	CcSEcCtD
Dicyclomine—Dermatitis—Clonidine—hypertension	4.4e-05	0.000183	CcSEcCtD
Dicyclomine—Anorexia—Lisinopril—hypertension	4.4e-05	0.000182	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Ramipril—hypertension	4.39e-05	0.000182	CcSEcCtD
Dicyclomine—Fatigue—Ramipril—hypertension	4.38e-05	0.000182	CcSEcCtD
Dicyclomine—Headache—Clonidine—hypertension	4.38e-05	0.000182	CcSEcCtD
Dicyclomine—Dyspepsia—Timolol—hypertension	4.38e-05	0.000182	CcSEcCtD
Dicyclomine—Hypersensitivity—Losartan—hypertension	4.37e-05	0.000181	CcSEcCtD
Dicyclomine—Asthenia—Betaxolol—hypertension	4.37e-05	0.000181	CcSEcCtD
Dicyclomine—Nausea—Valsartan—hypertension	4.36e-05	0.000181	CcSEcCtD
Dicyclomine—Pruritus—Furosemide—hypertension	4.35e-05	0.00018	CcSEcCtD
Dicyclomine—Constipation—Ramipril—hypertension	4.35e-05	0.00018	CcSEcCtD
Dicyclomine—Nausea—Olmesartan—hypertension	4.33e-05	0.00018	CcSEcCtD
Dicyclomine—Vomiting—Trandolapril—hypertension	4.33e-05	0.00018	CcSEcCtD
Dicyclomine—Decreased appetite—Timolol—hypertension	4.32e-05	0.000179	CcSEcCtD
Dicyclomine—Vomiting—Enalapril—hypertension	4.32e-05	0.000179	CcSEcCtD
Dicyclomine—Dizziness—Captopril—hypertension	4.31e-05	0.000179	CcSEcCtD
Dicyclomine—Pruritus—Betaxolol—hypertension	4.31e-05	0.000179	CcSEcCtD
Dicyclomine—Rash—Trandolapril—hypertension	4.3e-05	0.000178	CcSEcCtD
Dicyclomine—Dermatitis—Trandolapril—hypertension	4.29e-05	0.000178	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Timolol—hypertension	4.29e-05	0.000178	CcSEcCtD
Dicyclomine—Fatigue—Timolol—hypertension	4.29e-05	0.000178	CcSEcCtD
Dicyclomine—Rash—Enalapril—hypertension	4.28e-05	0.000178	CcSEcCtD
Dicyclomine—Dermatitis—Enalapril—hypertension	4.28e-05	0.000177	CcSEcCtD
Dicyclomine—Headache—Trandolapril—hypertension	4.27e-05	0.000177	CcSEcCtD
Dicyclomine—Vomiting—Telmisartan—hypertension	4.26e-05	0.000177	CcSEcCtD
Dicyclomine—Asthenia—Losartan—hypertension	4.25e-05	0.000177	CcSEcCtD
Dicyclomine—Headache—Enalapril—hypertension	4.25e-05	0.000176	CcSEcCtD
Dicyclomine—Pain—Timolol—hypertension	4.25e-05	0.000176	CcSEcCtD
Dicyclomine—Rash—Telmisartan—hypertension	4.22e-05	0.000175	CcSEcCtD
Dicyclomine—Dermatitis—Telmisartan—hypertension	4.22e-05	0.000175	CcSEcCtD
Dicyclomine—Pruritus—Losartan—hypertension	4.2e-05	0.000174	CcSEcCtD
Dicyclomine—Headache—Telmisartan—hypertension	4.2e-05	0.000174	CcSEcCtD
Dicyclomine—Feeling abnormal—Ramipril—hypertension	4.19e-05	0.000174	CcSEcCtD
Dicyclomine—Dizziness—Perindopril—hypertension	4.18e-05	0.000173	CcSEcCtD
Dicyclomine—Insomnia—Lisinopril—hypertension	4.17e-05	0.000173	CcSEcCtD
Dicyclomine—Dizziness—Irbesartan—hypertension	4.17e-05	0.000173	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Ramipril—hypertension	4.16e-05	0.000172	CcSEcCtD
Dicyclomine—Nausea—Clonidine—hypertension	4.15e-05	0.000172	CcSEcCtD
Dicyclomine—Paraesthesia—Lisinopril—hypertension	4.14e-05	0.000172	CcSEcCtD
Dicyclomine—Vomiting—Captopril—hypertension	4.14e-05	0.000172	CcSEcCtD
Dicyclomine—Dizziness—Hydrochlorothiazide—hypertension	4.13e-05	0.000171	CcSEcCtD
Dicyclomine—Dyspnoea—Lisinopril—hypertension	4.11e-05	0.000171	CcSEcCtD
Dicyclomine—Rash—Captopril—hypertension	4.11e-05	0.00017	CcSEcCtD
Dicyclomine—Dermatitis—Captopril—hypertension	4.1e-05	0.00017	CcSEcCtD
Dicyclomine—Somnolence—Lisinopril—hypertension	4.1e-05	0.00017	CcSEcCtD
Dicyclomine—Feeling abnormal—Timolol—hypertension	4.1e-05	0.00017	CcSEcCtD
Dicyclomine—Headache—Captopril—hypertension	4.08e-05	0.000169	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Timolol—hypertension	4.06e-05	0.000169	CcSEcCtD
Dicyclomine—Dizziness—Furosemide—hypertension	4.06e-05	0.000169	CcSEcCtD
Dicyclomine—Dyspepsia—Lisinopril—hypertension	4.06e-05	0.000168	CcSEcCtD
Dicyclomine—Nausea—Trandolapril—hypertension	4.05e-05	0.000168	CcSEcCtD
Dicyclomine—Urticaria—Ramipril—hypertension	4.04e-05	0.000168	CcSEcCtD
Dicyclomine—Nausea—Enalapril—hypertension	4.03e-05	0.000167	CcSEcCtD
Dicyclomine—Dizziness—Betaxolol—hypertension	4.02e-05	0.000167	CcSEcCtD
Dicyclomine—Vomiting—Perindopril—hypertension	4.02e-05	0.000167	CcSEcCtD
Dicyclomine—Abdominal pain—Ramipril—hypertension	4.02e-05	0.000167	CcSEcCtD
Dicyclomine—Decreased appetite—Lisinopril—hypertension	4.01e-05	0.000166	CcSEcCtD
Dicyclomine—Vomiting—Irbesartan—hypertension	4.01e-05	0.000166	CcSEcCtD
Dicyclomine—Rash—Perindopril—hypertension	3.99e-05	0.000165	CcSEcCtD
Dicyclomine—Dermatitis—Perindopril—hypertension	3.98e-05	0.000165	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Lisinopril—hypertension	3.98e-05	0.000165	CcSEcCtD
Dicyclomine—Nausea—Telmisartan—hypertension	3.98e-05	0.000165	CcSEcCtD
Dicyclomine—Fatigue—Lisinopril—hypertension	3.98e-05	0.000165	CcSEcCtD
Dicyclomine—Vomiting—Hydrochlorothiazide—hypertension	3.97e-05	0.000165	CcSEcCtD
Dicyclomine—Rash—Irbesartan—hypertension	3.97e-05	0.000165	CcSEcCtD
Dicyclomine—Dermatitis—Irbesartan—hypertension	3.97e-05	0.000165	CcSEcCtD
Dicyclomine—Headache—Perindopril—hypertension	3.96e-05	0.000164	CcSEcCtD
Dicyclomine—Urticaria—Timolol—hypertension	3.95e-05	0.000164	CcSEcCtD
Dicyclomine—Headache—Irbesartan—hypertension	3.95e-05	0.000164	CcSEcCtD
Dicyclomine—Constipation—Lisinopril—hypertension	3.94e-05	0.000164	CcSEcCtD
Dicyclomine—Pain—Lisinopril—hypertension	3.94e-05	0.000164	CcSEcCtD
Dicyclomine—Rash—Hydrochlorothiazide—hypertension	3.94e-05	0.000163	CcSEcCtD
Dicyclomine—Dermatitis—Hydrochlorothiazide—hypertension	3.94e-05	0.000163	CcSEcCtD
Dicyclomine—Abdominal pain—Timolol—hypertension	3.93e-05	0.000163	CcSEcCtD
Dicyclomine—Dizziness—Losartan—hypertension	3.92e-05	0.000163	CcSEcCtD
Dicyclomine—Headache—Hydrochlorothiazide—hypertension	3.92e-05	0.000162	CcSEcCtD
Dicyclomine—Vomiting—Furosemide—hypertension	3.91e-05	0.000162	CcSEcCtD
Dicyclomine—Rash—Furosemide—hypertension	3.88e-05	0.000161	CcSEcCtD
Dicyclomine—Dermatitis—Furosemide—hypertension	3.87e-05	0.000161	CcSEcCtD
Dicyclomine—Vomiting—Betaxolol—hypertension	3.87e-05	0.00016	CcSEcCtD
Dicyclomine—Nausea—Captopril—hypertension	3.87e-05	0.00016	CcSEcCtD
Dicyclomine—Headache—Furosemide—hypertension	3.85e-05	0.00016	CcSEcCtD
Dicyclomine—Rash—Betaxolol—hypertension	3.84e-05	0.000159	CcSEcCtD
Dicyclomine—Dermatitis—Betaxolol—hypertension	3.83e-05	0.000159	CcSEcCtD
Dicyclomine—Headache—Betaxolol—hypertension	3.81e-05	0.000158	CcSEcCtD
Dicyclomine—Feeling abnormal—Lisinopril—hypertension	3.8e-05	0.000158	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Lisinopril—hypertension	3.77e-05	0.000156	CcSEcCtD
Dicyclomine—Vomiting—Losartan—hypertension	3.77e-05	0.000156	CcSEcCtD
Dicyclomine—Nausea—Perindopril—hypertension	3.76e-05	0.000156	CcSEcCtD
Dicyclomine—Hypersensitivity—Ramipril—hypertension	3.75e-05	0.000155	CcSEcCtD
Dicyclomine—Nausea—Irbesartan—hypertension	3.74e-05	0.000155	CcSEcCtD
Dicyclomine—Rash—Losartan—hypertension	3.74e-05	0.000155	CcSEcCtD
Dicyclomine—Dermatitis—Losartan—hypertension	3.74e-05	0.000155	CcSEcCtD
Dicyclomine—Headache—Losartan—hypertension	3.72e-05	0.000154	CcSEcCtD
Dicyclomine—Nausea—Hydrochlorothiazide—hypertension	3.71e-05	0.000154	CcSEcCtD
Dicyclomine—Urticaria—Lisinopril—hypertension	3.66e-05	0.000152	CcSEcCtD
Dicyclomine—Hypersensitivity—Timolol—hypertension	3.66e-05	0.000152	CcSEcCtD
Dicyclomine—Nausea—Furosemide—hypertension	3.65e-05	0.000151	CcSEcCtD
Dicyclomine—Asthenia—Ramipril—hypertension	3.65e-05	0.000151	CcSEcCtD
Dicyclomine—Abdominal pain—Lisinopril—hypertension	3.65e-05	0.000151	CcSEcCtD
Dicyclomine—Nausea—Betaxolol—hypertension	3.61e-05	0.00015	CcSEcCtD
Dicyclomine—Pruritus—Ramipril—hypertension	3.6e-05	0.000149	CcSEcCtD
Dicyclomine—Asthenia—Timolol—hypertension	3.57e-05	0.000148	CcSEcCtD
Dicyclomine—Nausea—Losartan—hypertension	3.52e-05	0.000146	CcSEcCtD
Dicyclomine—Pruritus—Timolol—hypertension	3.52e-05	0.000146	CcSEcCtD
Dicyclomine—Hypersensitivity—Lisinopril—hypertension	3.4e-05	0.000141	CcSEcCtD
Dicyclomine—Dizziness—Ramipril—hypertension	3.36e-05	0.000139	CcSEcCtD
Dicyclomine—Asthenia—Lisinopril—hypertension	3.31e-05	0.000137	CcSEcCtD
Dicyclomine—Dizziness—Timolol—hypertension	3.29e-05	0.000136	CcSEcCtD
Dicyclomine—Pruritus—Lisinopril—hypertension	3.26e-05	0.000135	CcSEcCtD
Dicyclomine—Vomiting—Ramipril—hypertension	3.23e-05	0.000134	CcSEcCtD
Dicyclomine—Rash—Ramipril—hypertension	3.21e-05	0.000133	CcSEcCtD
Dicyclomine—Dermatitis—Ramipril—hypertension	3.2e-05	0.000133	CcSEcCtD
Dicyclomine—Headache—Ramipril—hypertension	3.19e-05	0.000132	CcSEcCtD
Dicyclomine—Vomiting—Timolol—hypertension	3.16e-05	0.000131	CcSEcCtD
Dicyclomine—Rash—Timolol—hypertension	3.13e-05	0.00013	CcSEcCtD
Dicyclomine—Dermatitis—Timolol—hypertension	3.13e-05	0.00013	CcSEcCtD
Dicyclomine—Headache—Timolol—hypertension	3.11e-05	0.000129	CcSEcCtD
Dicyclomine—Dizziness—Lisinopril—hypertension	3.05e-05	0.000127	CcSEcCtD
Dicyclomine—Nausea—Ramipril—hypertension	3.02e-05	0.000125	CcSEcCtD
Dicyclomine—Nausea—Timolol—hypertension	2.95e-05	0.000122	CcSEcCtD
Dicyclomine—Vomiting—Lisinopril—hypertension	2.93e-05	0.000122	CcSEcCtD
Dicyclomine—Rash—Lisinopril—hypertension	2.91e-05	0.000121	CcSEcCtD
Dicyclomine—Dermatitis—Lisinopril—hypertension	2.9e-05	0.000121	CcSEcCtD
Dicyclomine—Headache—Lisinopril—hypertension	2.89e-05	0.00012	CcSEcCtD
Dicyclomine—Nausea—Lisinopril—hypertension	2.74e-05	0.000114	CcSEcCtD
Dicyclomine—CHRM1—Signaling Pathways—GNAS—hypertension	6.1e-06	5.12e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—GNAS—hypertension	6.08e-06	5.11e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—hypertension	6.08e-06	5.1e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PIK3R1—hypertension	6.07e-06	5.09e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—RHOA—hypertension	6.05e-06	5.08e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PIK3R1—hypertension	6.05e-06	5.08e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—GNAS—hypertension	6.02e-06	5.06e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—COMT—hypertension	6.02e-06	5.05e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PPARA—hypertension	6.01e-06	5.04e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PIK3R1—hypertension	5.99e-06	5.03e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—APOB—hypertension	5.98e-06	5.02e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APOB—hypertension	5.96e-06	5e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PTK2—hypertension	5.95e-06	5e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GNB3—hypertension	5.94e-06	4.98e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PPARGC1A—hypertension	5.94e-06	4.98e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PTK2—hypertension	5.93e-06	4.98e-05	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—CXCL8—hypertension	5.93e-06	4.97e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—HMOX1—hypertension	5.91e-06	4.96e-05	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—CXCL8—hypertension	5.91e-06	4.96e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APOB—hypertension	5.9e-06	4.95e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—EDN1—hypertension	5.88e-06	4.94e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PTK2—hypertension	5.88e-06	4.93e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—EDN1—hypertension	5.86e-06	4.92e-05	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—CXCL8—hypertension	5.85e-06	4.91e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CCL5—hypertension	5.84e-06	4.9e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CAT—hypertension	5.83e-06	4.89e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—AGT—hypertension	5.82e-06	4.89e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CCL5—hypertension	5.82e-06	4.88e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—EDN1—hypertension	5.81e-06	4.87e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—hypertension	5.8e-06	4.87e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GNAS—hypertension	5.78e-06	4.85e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CCL5—hypertension	5.76e-06	4.84e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CALM1—hypertension	5.72e-06	4.8e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—LPL—hypertension	5.71e-06	4.79e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—APOE—hypertension	5.7e-06	4.79e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—LPL—hypertension	5.69e-06	4.78e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—H2AFX—hypertension	5.67e-06	4.76e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—APOB—hypertension	5.66e-06	4.75e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PDGFRB—hypertension	5.66e-06	4.75e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—RPS6KB1—hypertension	5.66e-06	4.75e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CAV1—hypertension	5.65e-06	4.74e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—H2AFX—hypertension	5.65e-06	4.74e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PDGFRB—hypertension	5.64e-06	4.73e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—RPS6KB1—hypertension	5.64e-06	4.73e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—APOA1—hypertension	5.64e-06	4.73e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—LPL—hypertension	5.63e-06	4.73e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—H2AFX—hypertension	5.59e-06	4.7e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ADCY5—hypertension	5.59e-06	4.69e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—RPS6KB1—hypertension	5.58e-06	4.69e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PDGFRB—hypertension	5.58e-06	4.69e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ADCY5—hypertension	5.57e-06	4.68e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PRKCG—hypertension	5.55e-06	4.66e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PRKCG—hypertension	5.53e-06	4.64e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ADCY5—hypertension	5.51e-06	4.63e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ITGB3—hypertension	5.51e-06	4.63e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PRKCA—hypertension	5.51e-06	4.63e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GSTM1—hypertension	5.51e-06	4.62e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PRKCA—hypertension	5.49e-06	4.61e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ITGB3—hypertension	5.49e-06	4.61e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PRKCG—hypertension	5.48e-06	4.6e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—YWHAZ—hypertension	5.47e-06	4.59e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—YWHAZ—hypertension	5.45e-06	4.57e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PRKCA—hypertension	5.44e-06	4.57e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ITGB3—hypertension	5.44e-06	4.57e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SPP1—hypertension	5.4e-06	4.54e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NGF—hypertension	5.4e-06	4.54e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—LPL—hypertension	5.4e-06	4.54e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—YWHAZ—hypertension	5.4e-06	4.53e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NGF—hypertension	5.39e-06	4.52e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SPP1—hypertension	5.39e-06	4.52e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CXCL8—hypertension	5.38e-06	4.52e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CXCL8—hypertension	5.36e-06	4.5e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SPP1—hypertension	5.34e-06	4.48e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NGF—hypertension	5.34e-06	4.48e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CXCL8—hypertension	5.31e-06	4.46e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ADCY5—hypertension	5.29e-06	4.44e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GPX1—hypertension	5.27e-06	4.43e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CCR5—hypertension	5.26e-06	4.41e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PRKCD—hypertension	5.26e-06	4.41e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CCR5—hypertension	5.24e-06	4.4e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PRKCD—hypertension	5.24e-06	4.4e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PRKCA—hypertension	5.22e-06	4.38e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CCR5—hypertension	5.19e-06	4.36e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PRKCD—hypertension	5.19e-06	4.36e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HTR2A—hypertension	5.15e-06	4.32e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—C3—hypertension	5.14e-06	4.31e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CD36—hypertension	5.14e-06	4.31e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HTR2A—hypertension	5.13e-06	4.31e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—C3—hypertension	5.12e-06	4.3e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HTR2A—hypertension	5.08e-06	4.26e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—C3—hypertension	5.07e-06	4.26e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PDGFB—hypertension	5e-06	4.2e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PDGFB—hypertension	4.99e-06	4.19e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—FGFR1—hypertension	4.98e-06	4.18e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PPARG—hypertension	4.97e-06	4.17e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—FGFR1—hypertension	4.96e-06	4.16e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PDGFB—hypertension	4.94e-06	4.14e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FGFR1—hypertension	4.91e-06	4.12e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HIF1A—hypertension	4.9e-06	4.11e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—POMC—hypertension	4.9e-06	4.11e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HIF1A—hypertension	4.88e-06	4.1e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AGT—hypertension	4.88e-06	4.1e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—INS—hypertension	4.87e-06	4.09e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AGT—hypertension	4.87e-06	4.09e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—MTHFR—hypertension	4.87e-06	4.09e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HIF1A—hypertension	4.84e-06	4.06e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AGT—hypertension	4.82e-06	4.05e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CALM1—hypertension	4.8e-06	4.03e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CALM1—hypertension	4.79e-06	4.02e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—LEP—hypertension	4.78e-06	4.02e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—APOE—hypertension	4.78e-06	4.02e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PPARA—hypertension	4.77e-06	4.01e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—LEP—hypertension	4.77e-06	4e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APOE—hypertension	4.77e-06	4e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CAV1—hypertension	4.74e-06	3.98e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CALM1—hypertension	4.74e-06	3.98e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—APOA1—hypertension	4.73e-06	3.97e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CAV1—hypertension	4.72e-06	3.97e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—LEP—hypertension	4.72e-06	3.96e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APOE—hypertension	4.72e-06	3.96e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APOA1—hypertension	4.71e-06	3.96e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—KDR—hypertension	4.69e-06	3.93e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CAV1—hypertension	4.68e-06	3.93e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—KDR—hypertension	4.67e-06	3.92e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APOA1—hypertension	4.67e-06	3.92e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—KDR—hypertension	4.63e-06	3.88e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—AGT—hypertension	4.62e-06	3.88e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CALM1—hypertension	4.55e-06	3.82e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—APOE—hypertension	4.53e-06	3.8e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—FN1—hypertension	4.51e-06	3.79e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—F2—hypertension	4.51e-06	3.79e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PRKCB—hypertension	4.51e-06	3.79e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—FN1—hypertension	4.5e-06	3.77e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PRKCB—hypertension	4.5e-06	3.77e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—F2—hypertension	4.5e-06	3.77e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CAV1—hypertension	4.49e-06	3.77e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—APOA1—hypertension	4.48e-06	3.76e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ALB—hypertension	4.47e-06	3.75e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FN1—hypertension	4.45e-06	3.74e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—F2—hypertension	4.45e-06	3.74e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PRKCB—hypertension	4.45e-06	3.74e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NOTCH1—hypertension	4.41e-06	3.71e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NOTCH1—hypertension	4.4e-06	3.69e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NOTCH1—hypertension	4.36e-06	3.66e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—NOS3—hypertension	4.27e-06	3.59e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PIK3R1—hypertension	4.27e-06	3.59e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—POMC—hypertension	4.11e-06	3.45e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—POMC—hypertension	4.1e-06	3.44e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—INS—hypertension	4.09e-06	3.43e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—INS—hypertension	4.07e-06	3.42e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—POMC—hypertension	4.06e-06	3.41e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—INS—hypertension	4.03e-06	3.39e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CCL2—hypertension	4.02e-06	3.38e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CCL2—hypertension	4.01e-06	3.36e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CCL2—hypertension	3.97e-06	3.33e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IGF1—hypertension	3.95e-06	3.32e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AKT2—hypertension	3.95e-06	3.32e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PPARG—hypertension	3.95e-06	3.31e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IGF1—hypertension	3.94e-06	3.31e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AKT2—hypertension	3.94e-06	3.31e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—EGFR—hypertension	3.93e-06	3.3e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—EGFR—hypertension	3.92e-06	3.29e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PTGS2—hypertension	3.91e-06	3.28e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IGF1—hypertension	3.9e-06	3.28e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AKT2—hypertension	3.9e-06	3.27e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—POMC—hypertension	3.89e-06	3.27e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—EGFR—hypertension	3.88e-06	3.26e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—INS—hypertension	3.87e-06	3.25e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SERPINE1—hypertension	3.75e-06	3.15e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SERPINE1—hypertension	3.74e-06	3.14e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SERPINE1—hypertension	3.71e-06	3.11e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—FGF2—hypertension	3.63e-06	3.05e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—FGF2—hypertension	3.62e-06	3.04e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—RHOA—hypertension	3.62e-06	3.04e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—RHOA—hypertension	3.61e-06	3.03e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FGF2—hypertension	3.59e-06	3.01e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PIK3R1—hypertension	3.58e-06	3.01e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NOS3—hypertension	3.58e-06	3.01e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—RHOA—hypertension	3.57e-06	3e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NOS3—hypertension	3.57e-06	3e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PIK3R1—hypertension	3.57e-06	3e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ALB—hypertension	3.55e-06	2.98e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NOS3—hypertension	3.54e-06	2.97e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PIK3R1—hypertension	3.54e-06	2.97e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PTEN—hypertension	3.41e-06	2.86e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PIK3R1—hypertension	3.39e-06	2.85e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—NOS3—hypertension	3.39e-06	2.85e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—RELA—hypertension	3.37e-06	2.83e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—RELA—hypertension	3.36e-06	2.82e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—RELA—hypertension	3.33e-06	2.8e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MTOR—hypertension	3.31e-06	2.78e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MTOR—hypertension	3.3e-06	2.77e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MTOR—hypertension	3.27e-06	2.74e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—EP300—hypertension	3.25e-06	2.73e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CXCL8—hypertension	3.18e-06	2.67e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CXCL8—hypertension	3.17e-06	2.66e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CXCL8—hypertension	3.14e-06	2.63e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PTGS2—hypertension	3.1e-06	2.61e-05	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—AKT1—hypertension	3.07e-06	2.58e-05	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—AKT1—hypertension	3.06e-06	2.57e-05	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—AKT1—hypertension	3.03e-06	2.54e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—IL6—hypertension	3.02e-06	2.54e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—IL6—hypertension	3.01e-06	2.53e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—IL6—hypertension	2.98e-06	2.5e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MMP9—hypertension	2.88e-06	2.41e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MMP9—hypertension	2.87e-06	2.41e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CDKN1A—hypertension	2.86e-06	2.41e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PTEN—hypertension	2.86e-06	2.4e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CDKN1A—hypertension	2.86e-06	2.4e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PTEN—hypertension	2.85e-06	2.39e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MMP9—hypertension	2.84e-06	2.38e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CDKN1A—hypertension	2.83e-06	2.37e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PTEN—hypertension	2.82e-06	2.37e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MAPK8—hypertension	2.8e-06	2.35e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—AKT1—hypertension	2.79e-06	2.34e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MAPK8—hypertension	2.79e-06	2.34e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—AKT1—hypertension	2.78e-06	2.33e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MAPK8—hypertension	2.76e-06	2.32e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—AKT1—hypertension	2.75e-06	2.31e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—EP300—hypertension	2.73e-06	2.29e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—EP300—hypertension	2.72e-06	2.28e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PTEN—hypertension	2.71e-06	2.27e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—EP300—hypertension	2.69e-06	2.26e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SRC—hypertension	2.65e-06	2.23e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SRC—hypertension	2.64e-06	2.22e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SRC—hypertension	2.62e-06	2.2e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—VEGFA—hypertension	2.58e-06	2.17e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—EP300—hypertension	2.58e-06	2.17e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—VEGFA—hypertension	2.57e-06	2.16e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—VEGFA—hypertension	2.55e-06	2.14e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MYC—hypertension	2.38e-06	1.99e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TGFB1—hypertension	2.37e-06	1.99e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MYC—hypertension	2.37e-06	1.99e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TGFB1—hypertension	2.36e-06	1.98e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MYC—hypertension	2.34e-06	1.97e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TGFB1—hypertension	2.34e-06	1.96e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—EGFR—hypertension	2.32e-06	1.95e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—EGFR—hypertension	2.32e-06	1.94e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—EGFR—hypertension	2.29e-06	1.93e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—AKT1—hypertension	1.96e-06	1.65e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TP53—hypertension	1.95e-06	1.64e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TP53—hypertension	1.94e-06	1.63e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TP53—hypertension	1.93e-06	1.62e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IL6—hypertension	1.79e-06	1.5e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IL6—hypertension	1.78e-06	1.49e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IL6—hypertension	1.76e-06	1.48e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AKT1—hypertension	1.65e-06	1.38e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AKT1—hypertension	1.64e-06	1.38e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AKT1—hypertension	1.63e-06	1.37e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—AKT1—hypertension	1.56e-06	1.31e-05	CbGpPWpGaD
